Russian lung cancer care under the microscope: 1500 patients tracked

NCT ID NCT06245837

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how doctors in Russia treat advanced or metastatic non-small-cell lung cancer in everyday practice. Researchers will follow about 1500 adults across 20 cancer centers to see which treatments and genetic tests are used. The goal is to understand real-world care patterns, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Research Site

Arkhangelsk, Russia
Research Site

Barnaul, Russia
Research Site

Irkutsk, Russia
Research Site

Kemerovo, Russia
Research Site

Kostroma, Russia
Research Site

Krasnoyarsk, Russia
Research Site

Moscow, Russia
Research Site

Novokuznetsk, Russia
Research Site

Novosibirsk, Russia
Research Site

Obninsk, Russia
Research Site

Perm, Russia
Research Site

Saint Petersburg, Russia
Research Site

Ufa, Russia
Research Site

Vladivostok, Russia
Research Site

Yaroslavl, Russia
Research Site

Yekaterinburg, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.